BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35043518)

  • 1. HSP90 promotes radioresistance of cervical cancer cells via reducing FBXO6-mediated CD147 polyubiquitination.
    Song Q; Wen J; Li W; Xue J; Zhang Y; Liu H; Han J; Ning T; Lu Z
    Cancer Sci; 2022 Apr; 113(4):1463-1474. PubMed ID: 35043518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBXO6-mediated RNASET2 ubiquitination and degradation governs the development of ovarian cancer.
    Ji M; Zhao Z; Li Y; Xu P; Shi J; Li Z; Wang K; Huang X; Liu B
    Cell Death Dis; 2021 Mar; 12(4):317. PubMed ID: 33767133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXO6-Mediated Ubiquitination and Degradation of Ero1L Inhibits Endoplasmic Reticulum Stress-Induced Apoptosis.
    Chen X; Duan LH; Luo PC; Hu G; Yu X; Liu J; Lu H; Liu B
    Cell Physiol Biochem; 2016; 39(6):2501-2508. PubMed ID: 27855403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer.
    Pedroza-Torres A; Campos-Parra AD; Millan-Catalan O; Loissell-Baltazar YA; Zamudio-Meza H; Cantú de León D; Montalvo-Esquivel G; Isla-Ortiz D; Herrera LA; Ángeles-Zaragoza Ó; Robelo-Romero G; Herrera-Gómez Á; Pérez-Plasencia C
    Oncol Rep; 2018 Mar; 39(3):1532-1540. PubMed ID: 29399698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer.
    Pranatharthi A; Thomas P; Udayashankar AH; Bhavani C; Suresh SB; Krishna S; Thatte J; Srikantia N; Ross CR; Srivastava S
    J Exp Clin Cancer Res; 2019 Sep; 38(1):392. PubMed ID: 31488179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Ubiquitin-like with Plant Homeodomain and RING Finger Domain 1 (UHRF1) Protein Stability by Heat Shock Protein 90 Chaperone Machinery.
    Ding G; Chen P; Zhang H; Huang X; Zang Y; Li J; Li J; Wong J
    J Biol Chem; 2016 Sep; 291(38):20125-35. PubMed ID: 27489107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.
    Liu B; Zheng Y; Wang TD; Xu HZ; Xia L; Zhang J; Wu YL; Chen GQ; Wang LS
    J Proteome Res; 2012 Mar; 11(3):1773-81. PubMed ID: 22268729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Fbxo6 inactivates spindle checkpoint by interacting with Mad2 and BubR1.
    Xu HZ; Wang ZQ; Shan HZ; Zhou L; Yang L; Lei H; Liu B; Wu YL
    Cell Cycle; 2018; 17(24):2779-2789. PubMed ID: 30526252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSP90 inhibition as a means of radiosensitizing resistant, aggressive soft tissue sarcomas.
    Ernst A; Anders H; Kapfhammer H; Orth M; Hennel R; Seidl K; Winssinger N; Belka C; Unkel S; Lauber K
    Cancer Lett; 2015 Sep; 365(2):211-22. PubMed ID: 26044951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV16 E6/E7 stabilize PGK1 protein by reducing its poly-ubiquitination in cervical cancer.
    Liu S; Song L; Yao H; Zhang L
    Cell Biol Int; 2022 Mar; 46(3):370-380. PubMed ID: 34882921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HAb18G/CD147 promotes radioresistance in hepatocellular carcinoma cells: a potential role for integrin β1 signaling.
    Wu J; Li Y; Dang YZ; Gao HX; Jiang JL; Chen ZN
    Mol Cancer Ther; 2015 Feb; 14(2):553-63. PubMed ID: 25534361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-375 Modulates Radiosensitivity of HR-HPV-Positive Cervical Cancer Cells by Targeting UBE3A through the p53 Pathway.
    Song L; Liu S; Zeng S; Zhang L; Li X
    Med Sci Monit; 2015 Jul; 21():2210-7. PubMed ID: 26224081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation sensitivity assay with a panel of patient-derived spheroids of small cell carcinoma of the cervix.
    Nakajima A; Endo H; Okuyama H; Kiyohara Y; Kimura T; Kamiura S; Hiraoka M; Inoue M
    Int J Cancer; 2015 Jun; 136(12):2949-60. PubMed ID: 25408479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fbxo6 confers drug-sensitization to cisplatin via inhibiting the activation of Chk1 in non-small cell lung cancer.
    Cai L; Li J; Zhao J; Guo Y; Xie M; Zhang X; Wang L; Tian H; Li A; Li Q; Miao Y
    FEBS Lett; 2019 Jul; 593(14):1827-1836. PubMed ID: 31140586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of CD147 isoform‑4 in the proliferation of SiHa cells: a possible molecular mechanism of cervical cancer.
    Wu Y; Zhou X; Zheng PS
    Oncol Rep; 2011 Sep; 26(3):717-24. PubMed ID: 21687950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition.
    Gomez-Casal R; Epperly MW; Wang H; Proia DA; Greenberger JS; Levina V
    Oncotarget; 2015 Dec; 6(42):44306-22. PubMed ID: 26517240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis.
    Yuan W; Xiaoyun H; Haifeng Q; Jing L; Weixu H; Ruofan D; Jinjin Y; Zongji S
    Int J Med Sci; 2014; 11(7):691-6. PubMed ID: 24843318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma.
    Huang XQ; Chen X; Xie XX; Zhou Q; Li K; Li S; Shen LF; Su J
    Int J Clin Exp Pathol; 2014; 7(4):1651-66. PubMed ID: 24817962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX2 regulates radioresistance in cervical cancer via the hedgehog signaling pathway.
    Huang C; Lu H; Li J; Xie X; Fan L; Wang D; Tan W; Wang Y; Lin Z; Yao T
    Gynecol Oncol; 2018 Dec; 151(3):533-541. PubMed ID: 30336948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HSP90β Improves Lipid Disorders by Promoting Mature SREBPs Degradation via the Ubiquitin-proteasome System.
    Zheng ZG; Zhang X; Liu XX; Jin XX; Dai L; Cheng HM; Jing D; Thu PM; Zhang M; Li H; Zhu J; Liu C; Xue B; Li Y; Chen L; Peng C; Zhu W; Wang L; Liu J; Li HJ; Li P; Xu X
    Theranostics; 2019; 9(20):5769-5783. PubMed ID: 31534518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.